FDA Recalls, Market Withdrawals & Safety AlertsOther / 其他

Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg

Recall fda-alert:2020-07-08:Lupin:Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mgPublished 2020-07-08Company Lupin Pharmaceuticals, Inc.

Reason / 召回原因N-Nitrosodimethylamine (NDMA) Impurity

Distribution / 销售地区Not provided in the official record

Code information / 批次信息Not provided in the official record

Official-information notice / 官方信息说明
This page organizes fields from the named agency record. It is not medical, legal, or food-safety advice. Always compare your package with the official notice.

Official record details

官方记录详情：以原始机构公告为准

Recall number / 召回编号

fda-alert:2020-07-08:Lupin:Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg

Classification / 风险等级

Other / 其他

Published / 发布时间

2020-07-08

Recalling firm / 召回企业

Lupin Pharmaceuticals, Inc.

Product description / 产品描述

Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg

Product code / 产品代码

Not provided in the official record

Code information / 批次与代码信息

Not provided in the official record

Product quantity / 产品数量

Not provided in the official record

Distribution / 销售地区

Not provided in the official record

Reason for recall / 召回原因

N-Nitrosodimethylamine (NDMA) Impurity

Need the original notice?
Open the agency source for the complete official notice and any disposal, return, or contact instructions.

Open official source ↗

← Return to Recall Radar search / 返回搜索雷达

Last synchronized: 2020-07-08. Recall Radar does not replace agency guidance.